Recombinant human erythropoietin mutants and therapeutic methods employing them
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 25, 1997
Issued Date -
N/A
app pub date -
Feb 2, 1995
filing date -
Jul 28, 1992
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
DNA encoding modified, secretable erythropoietin proteins whose ability to regulate the growth and differentiation of red blood cell progenitors are different from the wildtype recombinant erythropoietin and to methods of modifying or altering the regulating activity of a secretable erythropoietin and using modified secretable erythropoietin proteins.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully